- Capital Cube•2 months ago
Click here to see latest analysisChemoCentryx, Inc. reports financial results for the quarter ended March 31, 2016.AnalysisSummary numbers: Revenues of USD 0 million, Net Earnings of USD -15.24 million.The company did not record any revenues for the last twelve months making the comparison of net margin versus asset turnover meaningless.CCXI-US‘s earnings and EBITDA are both […] (Read more...) The post ChemoCentryx, Inc. :CCXI-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016 appeared first on CapitalCube.
After hours: 4.630.00 (0.00%) as of 4:44 PM EDT
|Bid||2.76 x 600|
|Ask||5.00 x 2500|
|52wk Range||1.92 - 8.78|
|Day's Range||4.57 - 4.70|
|Avg Vol (3m)||1,381,433|
As of 4:00 PM EDT. Market closed.